Kontafarma China Holdings (HKSE:01312) FCF Margin % : 6.13% (As of Dec. 2023)

View and export this data going back to 2012. Start your Free Trial

What is Kontafarma China Holdings FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Kontafarma China Holdings's Free Cash Flow for the six months ended in Dec. 2023 was HK$23.2 Mil. Kontafarma China Holdings's Revenue for the six months ended in Dec. 2023 was HK$378.4 Mil. Therefore, Kontafarma China Holdings's FCF Margin % for the quarter that ended in Dec. 2023 was 6.13%.

As of today, Kontafarma China Holdings's current FCF Yield % is 7.01%.

The historical rank and industry rank for Kontafarma China Holdings's FCF Margin % or its related term are showing as below:

HKSE:01312' s FCF Margin % Range Over the Past 10 Years
Min: -24.53 Med: -6.05 Max: 2.58
Current: 1.6

During the past 13 years, the highest FCF Margin % of Kontafarma China Holdings was 2.58%. The lowest was -24.53%. And the median was -6.05%.

HKSE:01312's FCF Margin % is ranked better than
54.72% of 1027 companies
in the Drug Manufacturers industry
Industry Median: -0.12 vs HKSE:01312: 1.60

Kontafarma China Holdings FCF Margin % Historical Data

The historical data trend for Kontafarma China Holdings's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kontafarma China Holdings FCF Margin % Chart

Kontafarma China Holdings Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-7.01

2.58

-6.14

-6.02

1.60

Kontafarma China Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															4.07	-9.15	-2.84	-2.39	6.13

Competitive Comparison of Kontafarma China Holdings's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Kontafarma China Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kontafarma China Holdings's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kontafarma China Holdings's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Kontafarma China Holdings's FCF Margin % falls into.

Kontafarma China Holdings FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Kontafarma China Holdings's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	12.924	/	809.107
	=	1.60 %

Kontafarma China Holdings's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	23.197	/	378.402
	=	6.13 %

Kontafarma China Holdings FCF Margin % Related Terms

Thank you for viewing the detailed overview of Kontafarma China Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kontafarma China Holdings (HKSE:01312) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kontafarma China Holdings Ltd (HKSE:01312) » Definitions » FCF Margin %

Traded in Other Exchanges

N/A

Address

30 Harbour Road, Room 12A 09-20, 12th Floor, Sun Hung Kai Centre, Wanchai, Hong Kong, HKG

Website

https://www.kontafarma.com.hk

Kontafarma China Holdings Ltd is principally engaged in the manufacture and sale of prescription drugs including chemical drugs and traditional Chinese medicine in the PRC, and the operation of fitness centers, provision of fitness and health consulting services, and the operation of franchises. The operating segments include pharmaceutical business and Fitness business. Majority of its revenue derives from pharmaceutical business segment.

Kontafarma China Holdings (HKSE:01312) Headlines

No Headlines